Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2016 · second_quarter · Q2
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Source: Senate LDA
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests Cancer "Moonshot" initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Calling for Sickle Cell Trait research.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2017
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention (S.3040) Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Making further continuing appropriations for fiscal year 2016, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Bipartisan Budget Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600)
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Patients' Access to Treatments Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Medicare Access and CHIP Reauthorization Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Consolidated Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Further Continuing Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
To amend title XI of the Social Security Act to exempt from manufacturer transparency reporting certain transfers used for educational purposes, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 *(H.R. 3020/S. 1695)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative regulation of laboratory developed tests
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
21st Century Cures Act
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6)
Continuing Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Calling for Sickle Cell Trait research.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6)
Calling for Sickle Cell Trait research.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative regulation of laboratory developed tests
Calling for Sickle Cell Trait research.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Cancer Drug Coverage Parity Act of 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 *(H.R. 3020/S. 1695)
Continuing Appropriations Resolution, 2015
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention; Public Health Program Funding; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; Continuing Appropriations Resolution, 2015 (H.J.Res. 124)
Making further continuing appropriations for fiscal year 2015, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, 2015 FY 2015 Continuing Resolution (through December 13, 2014)(H.J.Res. 130) FY 2015 Continuing Resolution (through December 17, 2014)(H.J.Res. 131) FY 2015 Omnibus, Consolidated and Further Continuing Appropriations Act (H.R. 83)
Making further continuing appropriations for fiscal year 2015, and for other purposes.
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, 2015 FY 2015 Continuing Resolution (through December 13, 2014)(H.J.Res. 130) FY 2015 Continuing Resolution (through December 17, 2014)(H.J.Res. 131) FY 2015 Omnibus, Consolidated and Further Continuing Appropriations Act (H.R. 83)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)
Cancer Drug Coverage Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implimentation of The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879)
SGR Repeal and Medicare Beneficiary Access Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act(P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
Protecting Access to Medicare Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
Protecting Access to Medicare Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act(P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Protecting Access to Medicare Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
Protecting Access to Medicare Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
Patients' Access to Treatments Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Patients' Access to Treatments Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Patients' Access to Treatments Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
FY 2014 and FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014 (S. 1284) FY 2014 Consolidated Appropriations Act (H.R. 3547)
Cancer Treatment Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Cancer Treatment Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Cancer Treatment Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)
Cancer Treatment Parity Act of 2013
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implimentation of The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879)
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act(P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: AMERICAN SOCIETY OF HEMATOLOGY · Firm: AMERICAN SOCIETY OF HEMATOLOGY
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (P.L. 114-10) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), Office of the Vice President of the United States, SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2016 · first_quarter · Q1
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
FY 2017 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2015 · fourth_quarter · Q4
Implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) FY 2016 Continuing Resolutions (H.R. 2250; H.J.Res. 78) FY 2016 Consolidated Appropriations Act (H.R. 2029) Bipartisan Budget Act of 2015 (H.R. 1314) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Regulation of laboratory developed tests
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative Issues impacting coverage for hematologic diseases and conditions
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE, Veterans Affairs, Dept of (VA)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2015 · third_quarter · Q3
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
implementation of the Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative regulation of laboratory developed tests
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 (H.R. 3020/S. 1695) Continuing Appropriations Act, 2016 (H.R. 719) 21st Century Cures Act (H.R. 6) Innovation for Healthier Americans initiative
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2015 · second_quarter · Q2
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations The Protect Continuing Physician Education and Patient Care Act (H.R.293)
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600) Cancer Drug Coverage Parity Act (S. 1566/H.R. 2739) 21st Century Cures Act (H.R. 6)
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues Clinical Trials Regulations H.Res. 296, calling for sickle cell trait research 21st Century Cures Act (H.R. 6)
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2016 *(H.R. 3020/S. 1695)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2015 · first_quarter · Q1
Medicare Access and CHIP Reauthorization Act of 2015 (H.R. 2) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Patients' Access to Treatments Act (H.R. 1600)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2014 · fourth_quarter · Q4
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act(P.L. 111-148) CMS National Coverage Determination Clinical Trials Regulations
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage Cancer Drug Coverage Parity Act (H.R. 1801) Cancer Treatment Parity Act (S. 1879) Patients' Access to Treatments Act (H.R. 460)
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2014 · third_quarter · Q3
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention; Public Health Program Funding; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015; Continuing Appropriations Resolution, 2015 (H.J.Res. 124)
Sickle Cell Disease/Trait; Hematology/Oncology Treatment Issues; General Hematology Public Health and Research Issues
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2014 · second_quarter · Q2
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
SGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015/S. 2000); Protecting Access to Medicare Act of 2014 (H.R. 4302); Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); CMS National Coverage Determination; Clinical Trials Regulations
AMERICAN SOCIETY OF HEMATOLOGY via AMERICAN SOCIETY OF HEMATOLOGY
2014 · first_quarter · Q1
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
FY 2014 and FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2014 (S. 1284) FY 2014 Consolidated Appropriations Act (H.R. 3547)
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) Hematology and Oncology Drug Research and Approval Issues Implimentation of The Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144) Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879)
FY 2016 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention Public Health Program Funding Departments of Labor, HHS, and Education, and Related Agencies Appropriations Act, 2015 FY 2015 Continuing Resolution (through December 13, 2014)(H.J.Res. 130) FY 2015 Continuing Resolution (through December 17, 2014)(H.J.Res. 131) FY 2015 Omnibus, Consolidated and Further Continuing Appropriations Act (H.R. 83)
Sickle Cell Disease/Trait Hematology/Oncology Treatment Issues General Hematology Public Health and Research Issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148); Hematology and Oncology Drug Research and Approval Issues; Implementation of the Food and Drug Administration Safety and Innovation Act (FDASIA) (P.L. 112-144); Clinical Trials Regulations and Coverage; Cancer Drug Coverage Parity Act (H.R. 1801); Cancer Treatment Parity Act (S. 1879); Patients' Access to Treatments Act (H.R. 460)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
FY 2015 Funding for the National Institutes of Health and Centers for Disease Control and Prevention; Public Health Program Funding; Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2015
Sickle Cell Disease/Trait; Hematology/Oncology Treatment Issues; General Hematology Public Health and Research Issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Medicare Patient Access and Quality Improvement Act of 2013 (H.R. 2810) Implementation of Health Reform Legislation/Patient Protection and Affordable Care Act (P.L. 111-148) CMS National Coverage Determination Clinical Trials RegulationsSGR Repeal and Medicare Provider Payment Modernization Act (H.R. 4015 / S. 2000) Protecting Access to Medicare Act of 2014 (H.R. 4302)
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE